ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 94945 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 94945; 2) Community: the network communities that were significantly associated with the response to NSC 94945; 3) Molecule: the relationships between components within communities and NSC 94945; 4) MDR: the compounds that were significantly associated with the NSC 94945.

NSC Compound Enrichment Correlation
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0174989034030623 -0.031987207
NSC 754245 5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione 0.0174989034030623 0.11771279
NSC 763703 (Z)-6-chloro-3-((2-(4-methoxyphenyl)-3H-benzo[d]imidazol-5-yl)methylene)indolin-2-one 0.0174989034030623 0.041882956
NSC 158263 Indoline, 5-chloro-1,3,3-trimethyl-2-methylene- (8CI) 0.0178844438004195 0.20992157
NSC 278619 L-Arabinose, 2-amino-4-[(2-amino-1-oxopropyl)amino]-2,4-dideoxy-, monohydrochloride 0.0178844438004195 0.10355734
NSC 302991 Camptothecin Derivative 0.0178844438004195 0.12624943
NSC 376265 Piperazine-1-carbothioic acid, 4-cycloheptyl-, [1-(2-pyridyl)ethylidene]hydrazide 0.0178844438004195 0.037879574
NSC 57958 Null 0.0178844438004195 -0.14347958
NSC 624358 Tricyclo[4.4.0.0(2,7)]decane-5-one, 4,4-dibromo-2-methyl- 0.0178844438004195 -0.1267928
NSC 633497 Null 0.0178844438004195 -0.05454757
Total:76  Current:26    [First] [Prev] [Next] [Last]